| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| 2 | 1 | - | 5 | 69 | 45 | 7 | 129 |
| - | - | - | 2 | 46 | 23 | 12 | 83 |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| 55 | 108 | 6 | 4 | 173 |
| 18 | 52 | - | - | 70 |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LOP(L) | 173 | 54.9% | -1.31 | 70 | 42.2% |
| LO(L) | 129 | 41.0% | -0.64 | 83 | 50.0% |
| Optic-unspecified(L) | 13 | 4.1% | 0.00 | 13 | 7.8% |
| upstream partner | # | NT | conns LO_LOP_unclear | % In | CV |
|---|---|---|---|---|---|
| TmY9a (L) | 10 | ACh | 23 | 7.8% | 0.4 |
| Y3 (L) | 6 | ACh | 22 | 7.5% | 0.6 |
| LPi2d (L) | 3 | Glu | 16 | 5.4% | 0.9 |
| TmY17 (L) | 6 | ACh | 16 | 5.4% | 0.8 |
| TmY13 (L) | 5 | ACh | 15 | 5.1% | 0.6 |
| T4a (L) | 10 | ACh | 14 | 4.8% | 0.5 |
| Tm5b (L) | 2 | ACh | 13 | 4.4% | 0.7 |
| LOLP1 (L) | 4 | GABA | 13 | 4.4% | 0.9 |
| TmY20 (L) | 4 | ACh | 13 | 4.4% | 0.5 |
| TmY9b (L) | 7 | ACh | 11 | 3.7% | 0.5 |
| TmY4 (L) | 4 | ACh | 10 | 3.4% | 0.6 |
| LC20b (L) | 1 | Glu | 9 | 3.1% | 0.0 |
| TmY19b (L) | 3 | GABA | 8 | 2.7% | 0.2 |
| OLVC6 (R) | 1 | Glu | 6 | 2.0% | 0.0 |
| LPi21 (L) | 1 | GABA | 6 | 2.0% | 0.0 |
| LPi3412 (L) | 2 | Glu | 6 | 2.0% | 0.7 |
| TmY10 (L) | 3 | ACh | 6 | 2.0% | 0.7 |
| Tm39 (L) | 3 | ACh | 6 | 2.0% | 0.4 |
| TmY15 (L) | 4 | GABA | 6 | 2.0% | 0.3 |
| T5a (L) | 6 | ACh | 6 | 2.0% | 0.0 |
| MeVC25 (L) | 1 | Glu | 5 | 1.7% | 0.0 |
| TmY18 (L) | 2 | ACh | 5 | 1.7% | 0.2 |
| Y14 (L) | 2 | Glu | 4 | 1.4% | 0.5 |
| LPi2e (L) | 1 | Glu | 3 | 1.0% | 0.0 |
| LPi4a (L) | 1 | Glu | 3 | 1.0% | 0.0 |
| MeLo14 (L) | 1 | Glu | 3 | 1.0% | 0.0 |
| Li31 (L) | 1 | Glu | 3 | 1.0% | 0.0 |
| LT36 (R) | 1 | GABA | 3 | 1.0% | 0.0 |
| T4d (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| LPLC4 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| MeLo8 (L) | 1 | GABA | 2 | 0.7% | 0.0 |
| LT39 (L) | 1 | GABA | 2 | 0.7% | 0.0 |
| LLPC1 (L) | 2 | ACh | 2 | 0.7% | 0.0 |
| Li21 (L) | 2 | ACh | 2 | 0.7% | 0.0 |
| Tm5c (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| T4b (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| Tm12 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| MeLo7 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| OLVC7 (R) | 1 | Glu | 1 | 0.3% | 0.0 |
| LPC2 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| Li14 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| Tm5a (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| Li35 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| Li18a (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| Tm36 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| T4c (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| TmY3 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| TmY16 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| TmY21 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LoVP32 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LC14a-1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| TmY19a (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LoVC17 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| Tm4 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| OLVC4 (R) | 1 | unc | 1 | 0.3% | 0.0 |
| LT46 (R) | 1 | GABA | 1 | 0.3% | 0.0 |
| LoVC18 (L) | 1 | DA | 1 | 0.3% | 0.0 |
| LoVC2 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LoVC22 (R) | 1 | DA | 1 | 0.3% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| LoVC12 (R) | 1 | GABA | 1 | 0.3% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 1 | 0.3% | 0.0 |
| downstream partner | # | NT | conns LO_LOP_unclear | % Out | CV |
|---|---|---|---|---|---|
| Y13 (L) | 6 | Glu | 61 | 13.2% | 0.9 |
| Y11 (L) | 6 | Glu | 40 | 8.6% | 0.6 |
| TmY9b (L) | 9 | ACh | 39 | 8.4% | 0.9 |
| Y14 (L) | 7 | Glu | 37 | 8.0% | 0.4 |
| Li14 (L) | 4 | Glu | 31 | 6.7% | 0.8 |
| VCH (R) | 1 | GABA | 25 | 5.4% | 0.0 |
| Tlp11 (L) | 3 | Glu | 18 | 3.9% | 0.8 |
| LPLC4 (L) | 1 | ACh | 16 | 3.5% | 0.0 |
| LoVC22 (R) | 2 | DA | 16 | 3.5% | 0.0 |
| TmY16 (L) | 2 | Glu | 14 | 3.0% | 0.7 |
| Li39 (R) | 1 | GABA | 13 | 2.8% | 0.0 |
| LPT31 (L) | 3 | ACh | 11 | 2.4% | 1.0 |
| Li26 (L) | 2 | GABA | 11 | 2.4% | 0.3 |
| TmY9a (L) | 5 | ACh | 11 | 2.4% | 0.7 |
| LoVP49 (L) | 1 | ACh | 10 | 2.2% | 0.0 |
| Li13 (L) | 2 | GABA | 9 | 1.9% | 0.8 |
| LoVC18 (L) | 2 | DA | 8 | 1.7% | 0.5 |
| Tlp13 (L) | 1 | Glu | 6 | 1.3% | 0.0 |
| Li18a (L) | 3 | GABA | 6 | 1.3% | 0.4 |
| Li22 (L) | 1 | GABA | 5 | 1.1% | 0.0 |
| LC10b (L) | 2 | ACh | 5 | 1.1% | 0.2 |
| Tm39 (L) | 2 | ACh | 5 | 1.1% | 0.2 |
| LC10d (L) | 3 | ACh | 5 | 1.1% | 0.6 |
| LT70 (L) | 1 | GABA | 4 | 0.9% | 0.0 |
| TmY10 (L) | 1 | ACh | 4 | 0.9% | 0.0 |
| Tm16 (L) | 2 | ACh | 4 | 0.9% | 0.5 |
| TmY20 (L) | 2 | ACh | 4 | 0.9% | 0.5 |
| TmY5a (L) | 2 | Glu | 4 | 0.9% | 0.5 |
| TmY17 (L) | 2 | ACh | 4 | 0.9% | 0.5 |
| Li35 (L) | 3 | GABA | 4 | 0.9% | 0.4 |
| LC13 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| Nod2 (L) | 1 | GABA | 3 | 0.6% | 0.0 |
| LoVC27 (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| Tm38 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LoVP101 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LC14b (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| LT80 (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| T4a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LLPC1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| TmY4 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| TmY19b (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| Li21 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tlp14 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LoVP29 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LPC2 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm20 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LC20a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| TmY19a (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| Y3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Li19 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| Li34a (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LoVC17 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LoVC2 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 1 | 0.2% | 0.0 |